Teva Pharmaceutical Indus Analyst Ratings
Monday.Com Analyst Ratings
Barclays Initiates Monday.com at Overweight With $275 Price Target
Semi Stocks Undergo Upgrades, Price Target Hikes on AI Demand: B Riley
Camtek Analyst Ratings
B. Riley Raises Price Target on Camtek to $150 From $110, Maintains Buy Rating
Pagaya Techs Analyst Ratings
Monday.Com Analyst Ratings
Pagaya Techs Analyst Ratings
Camtek Analyst Ratings
Wix.com Analyst Ratings
WalkMe Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
BofA Securities Adjusts Price Target on Nova to $245 From $220, Maintains Buy Rating
Wells Fargo Keeps Their Buy Rating on WalkMe (WKME)
Teva Pharmaceutical Indus Analyst Ratings
Wix.com Analyst Ratings
Pagaya Techs Analyst Ratings
Analysts' Opinions Are Mixed on These Technology Stocks: Pagaya Technologies Ltd (PGY) and Endava (DAVA)
WalkMe Analyst Ratings